amikacin has been researched along with Pneumonia in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (48.21) | 18.7374 |
1990's | 10 (17.86) | 18.2507 |
2000's | 4 (7.14) | 29.6817 |
2010's | 5 (8.93) | 24.3611 |
2020's | 10 (17.86) | 2.80 |
Authors | Studies |
---|---|
Honda, A; Ikeda, M; Kurokawa, M; Maki, H; Moriya, K; Sato, M; Toyama, K; Yamaguchi, R | 1 |
Chatterjee, A; Daley, CL; Hart, E; Hassan, M; Lesher, B; Obradovic, M; van Ingen, J | 1 |
Kidogawa, M; Nemoto, K; Yamasaki, K; Yatera, K | 1 |
Barzegar, KEF; Barzegar, PEF; Farjanikish, G; Hayati, FZ; Ranjbar, R; Tahmasebi, E; Tebyaniyan, H; Yazdanian, M | 1 |
Artigas, A; Battaglini, D; Bobi, J; Cabrera, R; Camprubí-Rimblas, M; Fernández-Barat, L; Ferrer-Segarra, A; Frigola, G; Kiarostami, K; Li Bassi, G; Martinez, D; Meli, A; Motos, A; Nicolau, DP; Pagliara, F; Pelosi, P; Rigol, M; Torres, A; Vila, J; Yang, H; Yang, M | 1 |
Ashizawa, N; Hirayama, T; Hosogaya, N; Ide, S; Ito, Y; Iwanaga, N; Izumikawa, K; Kido, T; Mukae, H; Obase, Y; Okano, S; Ozasa, M; Sakamoto, N; Takao, D; Takazono, T; Takeda, K; Takemoto, S; Tashiro, M; Yanagihara, K | 1 |
Adeleke, G; Egbagbe, E; Ejembi, J; Ettu, AO; Habib, A; Irowa, OO; Makanjuola, OB; Medugu, N; Mutiu, B; Ogunbosi, B; Ogunsola, F; Oladele, RO; Osinaike, T; Rotimi, V; Uwaezuoke, NS | 1 |
Aiesh, BM; Maali, Y; Omarya, S; Qandeel, F; Sabateen, A; Sholi, S; Taha, AA; Taha, SA; Zyoud, SH | 1 |
Kaku, N; Ota, K; Yanagihara, K | 1 |
Battaglini, D; Li Bassi, G; Motos, A; Torres, A | 1 |
Aguilera Xiol, E; Amaro, R; Antonelli, M; Artigas, A; Blasi, F; Bobi, J; Bringué, J; Carbonara, M; Chiurazzi, C; Comaru, T; Comino Trinidad, O; De Rosa, F; Fernandez-Barat, L; Fuster, C; Li Bassi, G; Marti, JD; Montgomery, AB; Motos, A; Nicolau, DP; Pelosi, P; Ramirez, J; Ranzani, OT; Rigol, M; Rinaudo, M; Saco, MA; Senussi, T; Torres, A; Yang, H | 1 |
Chen, Y; Liu, L | 1 |
Farrell, DJ; Jones, RN; Rhomberg, PR; Sader, HS | 1 |
Costa, SF; de Castro Lima, VA; de Maio Carrillho, CM; de Oliveira, LM; Gaudereto, JJ; Levin, AS; Martins, RC; Perozin, JS; Urbano, MR | 1 |
Kongthavonsakul, K; Oberdorfer, P; Washington, CH | 1 |
Xiang, XD; Yang, H; Yi, ZM | 1 |
De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L | 1 |
Fisher, S; James, G; Kurumunda, R; Mackinson, C; Malinin, V; Meers, P; Neville, M; Perkins, WR; Sardaryan, G; Scotto, AW | 1 |
Lietman, PS; Moore, RD; Smith, CR | 1 |
Niemierko, J; Rutkowski, B | 1 |
Berk, SL; Holtsclaw-Berk, SA; Kasprzyk, D; Ortega, G | 1 |
Kunieda, T; Nakagami, K; Noguchi, E; Osakabe, Y; Saruta, E; Satomi, T; Suzuki, H; Yatani, Y | 1 |
Brin, M; Donath, J; Kennish, A; Sanders, M; Wormser, GP | 1 |
Berk, SL; Gage, K; Ortega, G; Vracin, W | 1 |
Bao, ZD; Wu, ZG; Zheng, F | 1 |
Bolis, S; Bregani, R; Casaroli, I; Corneo, G; Lanzi, E; Mingozzi, S; Pioltelli, P; Pogliani, EM; Rossini, F; Viganó, F | 1 |
Hirose, S; Inoue, T; Ito, K; Mano, K; Mita, S; Morita, Y; Sukoh, M; Takahashi, T; Togano, Y; Yamanaka, K | 1 |
Cunha, BA; Domenico, P; Straus, DC; Woods, DE | 1 |
Balk, AH; de Man, RA; Groen, HJ; Hilvering, C | 1 |
Hidri, N; Jacolot, A; Leotard, S; Mimoz, O; Nordmann, P; Petitjean, O; Samii, K | 1 |
Harada, M; Kataoka, M; Kawata, N; Matsuo, K; Nabe, M; Okamoto, M; Tada, S; Takeuchi, M; Yamadori, I | 1 |
Abrutyn, E; Egert, J; Goodhart, GL; Root, RK; Watson, R | 1 |
Izawa, T; Katakura, K | 1 |
Hasegawa, Y; Masaoka, T; Nakamura, H; Shibata, H; Takubo, T; Ueda, T; Yoshitake, J | 1 |
Kimura, I; Kitagawa, N; Kitajima, K; Koui, F; Rai, MY; Takahashi, I; Tokioka, M; Yasui, M; Yorimitsu, S; Yoshizawa, K | 1 |
Bodey, GP; Feld, R; Rodriguez, V; Valdivieso, M | 1 |
Alford, RH; Leonard, JM; McGee, ZA | 1 |
Hayashi, I; Kaishio, K; Kawamorida, K; Konno, K; Kudo, S; Kurita, K; Nagai, K; Oizumi, K; Watanabe, A | 1 |
Dupont, C; Hammerberg, S; Marks, MI; Marks, S | 1 |
Levin, S; McKellar, PP; Rivera, N; Trenholme, GM | 1 |
Okamoto, Y; Okubo, H; Uba, F; Ueda, T; Ueda, Y | 1 |
Carmalt, ED; Finegold, SM; Lewis, RP; Meyer, RD | 1 |
Rong, XZ | 1 |
Bakhache, P; Chivet, C; Douchain, F; Houdas, S; Lebas, L; Pautard, JC | 1 |
Amstutz, P; Blanloeil, Y; Cathala, B; Chopin, C; Gouin, F; Grimaud, D; Le Gall, JR; Rouby, JJ; Tempe, JD; Vanooteghem-Delbarre, A | 1 |
Adland-Davenport, P; Brown, MP; Derendorf, HC; Robinson, JD | 1 |
Agusti Vidal, A; Almela, M; de Celis, R; Deulofeu, R; Marco, F; Rabinad, E; Rodriguez-Roisin, R; Torres, A | 1 |
Ramirez-Ronda, CH; Rivera-Vazquez, CR; Rodriguez, JR; Saavedra, S | 1 |
Beuscart, C; Drugeon, H; Leroy, O; Mouton, Y; Pappo, M | 2 |
Tao, YD | 1 |
Borrego Galán, JC; Chimpén Ruiz, VA; Mejía Molina, P; Zurdo García, JR | 1 |
Bonetti, A; Luthy, R; Siegenthaler, WE | 1 |
Katosova, LK; Nekhorosheva, AG; Skala, LZ; Sotnikova, GD; Volkov, IK | 1 |
Holloway, WJ | 1 |
Asada, H; Ito, A; Maruta, I; Matsuzaki, M; Ogawa, K | 1 |
3 review(s) available for amikacin and Pneumonia
Article | Year |
---|---|
Nontuberculous mycobacterial lung disease caused by
Topics: Amikacin; Cost of Illness; Humans; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia | 2021 |
Inhaled amikacin for severe Gram-negative pulmonary infections in the intensive care unit: current status and future prospects.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Gram-Negative Bacteria; Humans; Intensive Care Units; Pneumonia; Pseudomonas aeruginosa | 2018 |
Aminoglycoside antibiotics in infectious diseases. An overview.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Kanamycin; Kinetics; Neomycin; Netilmicin; Pneumonia; Sepsis; Sisomicin; Streptomycin; Tobramycin | 1986 |
10 trial(s) available for amikacin and Pneumonia
Article | Year |
---|---|
Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia.
Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Clinical Trials as Topic; Female; Gentamicins; Gram-Negative Bacteria; Humans; Male; Middle Aged; Pneumonia; Tobramycin | 1984 |
[Amelioration of aminoglycoside nephrotoxicity by Cordyceps sinensis in old patients].
Topics: Acetylglucosaminidase; Aged; Amikacin; Animals; beta 2-Microglobulin; Bronchitis; Drugs, Chinese Herbal; Female; Humans; Hypocreales; Kidney; Kidney Diseases; Male; Middle Aged; Moths; Pneumonia | 1994 |
Amikacin and ceftazidime as empirical antibiotic therapy in severely neutropenic patients: analysis of prognostic factors.
Topics: Adult; Amikacin; Antifungal Agents; Bacterial Infections; Cause of Death; Ceftazidime; Drug Combinations; Female; Humans; Length of Stay; Leukemia; Lymphoma; Male; Middle Aged; Mycoses; Neutropenia; Pneumonia; Prognosis; Prospective Studies; Remission Induction; Time Factors; Treatment Outcome | 1994 |
[Clinical evaluation of combination therapy of sulbactam/cefoperazone and aminoglycoside in respiratory tract infections].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bronchitis; Cefoperazone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia; Respiratory Tract Infections; Sulbactam; Tobramycin | 1994 |
Comparison of amikacin and tobramycin in the treatment of infection in patients with cancer.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Female; Humans; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Neoplasms; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tobramycin; Urinary Tract Infections | 1977 |
Evaluation of three antibiotic programs in newborn infants.
Topics: Amikacin; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Bilirubin; Cephalothin; Drug Therapy, Combination; Evaluation Studies as Topic; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Pneumonia; Sepsis; Tobramycin | 1978 |
Therapeutic efficacy of the combination of aztreonam with cefotaxime in the treatment of severe nosocomial pneumonia. Comparative study against amikacin combined with cefotaxime.
Topics: Adult; Aged; Amikacin; Aztreonam; Cefotaxime; Clinical Trials as Topic; Cross Infection; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia; Random Allocation | 1989 |
A comparative analysis of aztreonam + clindamycin versus tobramycin + clindamycin or amikacin + mezlocillin in the treatment of gram-negative lower respiratory tract infections.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Aztreonam; Bacterial Infections; Clindamycin; Clinical Trials as Topic; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Male; Mezlocillin; Middle Aged; Pneumonia; Random Allocation; Tobramycin | 1989 |
[Prospective randomized controlled study of a ceftazidime and pefloxacin combination versus a ceftazidime and amikacin combination in the empirical treatment of pneumonia and nosocomial septicemia at intensive care units].
Topics: Amikacin; Ceftazidime; Cross Infection; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Multicenter Studies as Topic; Pefloxacin; Pneumonia; Prospective Studies; Random Allocation; Sepsis | 1989 |
[Controlled randomized prospective study of a ceftazidime-pefloxacin combination versus a ceftazidime-amikacin combination in the empirical treatment of nosocomial pneumonias and septicemias of resuscitation. Preliminary results].
Topics: Amikacin; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Pefloxacin; Pneumonia; Prospective Studies; Random Allocation | 1988 |
43 other study(ies) available for amikacin and Pneumonia
Article | Year |
---|---|
Successful treatment of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa after allogeneic hematopoietic stem cell transplantation with colistin and amikacin inhalation therapy.
Topics: Amikacin; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Female; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Therapy | 2022 |
Liposomal Amikacin Inhalation Suspension-induced Pneumonitis.
Topics: Administration, Inhalation; Amikacin; Anti-Bacterial Agents; Humans; Liposomes; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonia | 2022 |
The comparative effects of erythromycin and amikacin on acute respiratory Pseudomonas aeruginosa infection.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Erythromycin; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Respiratory Tract Infections | 2023 |
Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Meropenem; Microbial Sensitivity Tests; Models, Theoretical; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Swine | 2023 |
A case of drug-induced organizing pneumonia caused by amikacin liposome inhalation suspension.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Female; Humans; Liposomes; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Organizing Pneumonia; Pneumonia | 2023 |
Antibiotic Guidelines for Critically Ill Patients in Nigeria.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Clavulanic Acid; Community-Acquired Infections; Critical Illness; Cross Infection; Fluconazole; Humans; Meropenem; Microbial Sensitivity Tests; Nigeria; Piperacillin, Tazobactam Drug Combination; Pneumonia; Prospective Studies; Urinary Tract Infections | 2023 |
Epidemiology and clinical characteristics of patients with carbapenem-resistant enterobacterales infections: experience from a large tertiary care center in a developing country.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Developing Countries; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Retrospective Studies; Sulfamethoxazole; Tertiary Care Centers; Trimethoprim | 2023 |
Efficacy of meropenem and amikacin combination therapy against carbapenemase-producing Klebsiella pneumoniae mouse model of pneumonia.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pneumonia | 2020 |
Nebulized Amikacin and Fosfomycin for Severe Pseudomonas aeruginosa Pneumonia: An Experimental Study.
Topics: Administration, Inhalation; Administration, Intravenous; Amikacin; Animals; Anti-Bacterial Agents; Bacterial Load; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fosfomycin; Lung; Meropenem; Nebulizers and Vaporizers; Pneumonia; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Random Allocation; Swine; Trachea | 2019 |
The treatment of nosocomial meningitis and brain abscess by carbapenem-resistant
Topics: Adult; Amikacin; Anti-Bacterial Agents; Brain Abscess; Carbapenem-Resistant Enterobacteriaceae; Cross Infection; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis; Meropenem; Microbial Sensitivity Tests; Pneumonia; Sulfamethoxazole | 2023 |
Arbekacin activity against contemporary clinical bacteria isolated from patients hospitalized with pneumonia.
Topics: Amikacin; Anti-Bacterial Agents; Dibekacin; Enterobacter; Humans; Klebsiella; Microbial Sensitivity Tests; Pneumonia; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 2015 |
Colistin-resistant Enterobacteriaceae infections: clinical and molecular characterization and analysis of in vitro synergy.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Kaplan-Meier Estimate; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia; Prospective Studies; Soft Tissue Infections; Tigecycline; Urinary Tract Infections | 2017 |
A 6-year-old boy with fever, rash and severe pneumonia.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefotaxime; Child; Diagnosis, Differential; Drug Therapy, Combination; Fever; Humans; Male; Measles; Pneumonia; Vitamin A | 2012 |
[Characteristics of bacteriology and drug sensitivity in patients with COPD combined with pneumonia].
Topics: Adult; Aged; Amikacin; Bacteria; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Pulmonary Disease, Chronic Obstructive; Vancomycin | 2003 |
In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pneumonia; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections.
Topics: Administration, Inhalation; Amikacin; Animals; Anti-Bacterial Agents; Biofilms; Colony Count, Microbial; Female; Liposomes; Lung; Pneumonia; Pseudomonas aeruginosa; Rats; Rats, Sprague-Dawley; Sputum | 2008 |
[Amikacin-induced hearing loss in patients treated with repeated hemodialysis].
Topics: Adult; Amikacin; Endocarditis, Bacterial; Female; Hearing Loss; Hearing Loss, Bilateral; Humans; Kanamycin; Kidney Failure, Chronic; Male; Middle Aged; Pneumonia; Renal Dialysis | 1984 |
Pasteurella multocida pneumonia in an elderly patient.
Topics: Age Factors; Aged; Amikacin; Cefamandole; Humans; Male; Pasteurella; Pasteurella Infections; Pneumonia | 1984 |
[A case of Klebsiella pneumonia with complication of CO2-narcosis successfully treated with amikacin (author's transl)].
Topics: Aged; Amikacin; Cognition Disorders; Humans; Hypercapnia; Infusions, Parenteral; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Male; Pneumonia | 1980 |
Fatal pneumonia. Emergence of an amikacin sulfate-resistant strain of Escherichia coli.
Topics: Amikacin; Drug Resistance, Microbial; Escherichia coli; Humans; Kanamycin; Male; Middle Aged; Pneumonia; Sepsis | 1981 |
Bacteremic group G streptococcal pneumonia.
Topics: Amikacin; Drug Therapy, Combination; Humans; Male; Middle Aged; Penicillin G Procaine; Pneumonia; Sepsis; Streptococcal Infections; Streptococcus | 1982 |
Salicylate potentiates amikacin therapy in rodent models of Klebsiella pneumoniae infection.
Topics: Amikacin; Animals; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Klebsiella Infections; Klebsiella pneumoniae; Mice; Neutropenia; Pneumonia; Rats; Rats, Sprague-Dawley; Sodium Salicylate; Survival Analysis | 1993 |
[Nocardiosis: a treacherous generalized infection].
Topics: Aged; Amikacin; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nocardia asteroides; Nocardia Infections; Pleural Effusion; Pneumonia; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
Efficacies of cefepime, ceftazidime, and imipenem alone or in combination with amikacin in rats with experimental pneumonia due to ceftazidime-susceptible or -resistant Enterobacter cloacae strains.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Imipenem; Injections, Intraperitoneal; Male; Microbial Sensitivity Tests; Pneumonia; Rats; Rats, Wistar; Thienamycins | 1998 |
[Pulmonary Nocardia otitidiscaviarum infection in an immunocompetent host].
Topics: Aged; Amikacin; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Humans; Immunocompromised Host; Male; Nocardia; Nocardia Infections; Pneumonia; Treatment Outcome | 2000 |
Community-acquired Acinetobacter calcoaceticus var anitratus pneumonia.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Alcoholism; Amikacin; Diagnostic Errors; Drug Resistance, Microbial; Female; Gentamicins; Humans; Liver Cirrhosis; Male; Middle Aged; Minocycline; Pneumonia; Sputum; Staining and Labeling; Tobramycin | 1977 |
[Treatment of Pseudomonas aeruginosa pneumonia with amikacin (author's transl)].
Topics: Adult; Amikacin; Female; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections | 1979 |
[Intravenous administration of amikacin sulfate for the infections complicated with hematologic disorders (author's transl)].
Topics: Adolescent; Adult; Amikacin; Anemia, Aplastic; Female; Hematologic Diseases; Humans; Infections; Injections, Intravenous; Kanamycin; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pneumonia; Sepsis | 1977 |
[Experience in combination therapy with amikacin, mainly by intravenous drip infusion of a large dose, for infections in acute leukaemia patients (author's transl)].
Topics: Adult; Aged; Amikacin; Bacterial Infections; Cephacetrile; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusions, Parenteral; Kanamycin; Leukemia, Myeloid, Acute; Male; Middle Aged; Pneumonia; Sulbenicillin | 1979 |
Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Gentamicins; Humans; In Vitro Techniques; Infant; Kanamycin; Male; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Serratia marcescens; Urinary Tract Infections | 1978 |
[Therapeutic effect of amikacin for infections with gram-negative bacilli, especially for stubborn respiratory infections (author's transl)].
Topics: Adult; Aged; Amikacin; Bronchiectasis; Chronic Disease; Drug Evaluation; Empyema; Female; Humans; Kanamycin; Lung Neoplasms; Male; Middle Aged; Pneumonia; Respiratory Tract Infections; Tuberculosis, Pulmonary; Urinary Tract Infections | 1978 |
Amikacin in the treatment of gram-negative pneumonia.
Topics: Adult; Aged; Amikacin; Gentamicins; Humans; Kanamycin; Middle Aged; Pneumonia | 1977 |
[Comparison of absorption and excretion of powdery preparation for injection and liquid preparation of BB-K8 (amikacin) (author's transl)].
Topics: Adult; Aged; Amikacin; Bronchitis; Cystitis; Drug Evaluation; Female; Humans; Injections, Intramuscular; Kanamycin; Male; Middle Aged; Pneumonia; Powders; Solutions | 1975 |
Amikacin therapy for serious gram-negative bacillary infections.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Ear, Inner; Female; Humans; Kanamycin; Kidney; Male; Middle Aged; Osteomyelitis; Peritonitis; Pneumonia; Sepsis; Urinary Tract Infections | 1975 |
[Experimental study of pulmonary infection and its systemic dissemination in the early stage of severe burn].
Topics: Amikacin; Animals; Burns; Disease Susceptibility; Endotoxins; Female; Male; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Sepsis | 1990 |
Variability of aminoglycosides pharmacokinesis in C.F. patients in relation with certain clinical parameters.
Topics: Amikacin; Anti-Bacterial Agents; Cystic Fibrosis; Female; Humans; Male; Pneumonia; Pseudomonas Infections; Tobramycin | 1990 |
[The results of antibiotic therapy in acute severe pneumonia dependent on the initial severity].
Topics: Acute Disease; Amikacin; Bacterial Infections; Drug Combinations; Female; Humans; Male; Middle Aged; Piperacillin; Pneumonia; Prognosis | 1990 |
Pharmacokinetics of amikacin in critically ill neonatal foals treated for presumed or confirmed sepsis.
Topics: Amikacin; Animals; Animals, Newborn; Horse Diseases; Horses; Immunization, Passive; Least-Squares Analysis; Pneumonia; Sepsis | 1990 |
[Klebsiella pneumonia. A report of 31 cases].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia; Polymyxins | 1987 |
[Pneumonia caused by Mycobacterium chelonei. Apropos of a case].
Topics: Aged; Aged, 80 and over; Amikacin; Cefotaxime; Female; Humans; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Pneumonia | 1988 |
[Clinico-bacteriological evaluation of the effectiveness of amikacin in chronic bronchopulmonary diseases and mucoviscidosis in children].
Topics: Adolescent; Amikacin; Bacterial Infections; Bronchiolitis; Child; Child, Preschool; Chronic Disease; Cystic Fibrosis; Drug Resistance, Microbial; Humans; Infant; Pneumonia | 1987 |
Management of sepsis in the elderly.
Topics: Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Pneumonia; Risk; Shock, Septic; Urinary Tract Infections | 1986 |
[Clinical evaluation of amikacin by intravenous drip infusion for infections in the field of internal medicine].
Topics: Acinetobacter Infections; Adult; Aged; Amikacin; Bacterial Infections; Cystitis; Female; Humans; Infusions, Parenteral; Kanamycin; Leukemia; Male; Middle Aged; Pneumonia; Respiratory Tract Infections; Sepsis | 1985 |